Author: ALLISON GATLIN
Source
Lilly’s new weight-loss drug could top $62 billion in 2030 sales, an analyst said Friday as he boosted his price target on Eli Lilly stock to 1,000.
The post How The Red-Hot Obesity Space Could Help Eli Lilly Join The 1,000 Club appeared first on Investor’s Business Daily.